CHUM Hôpital Notre-Dame

Montreal, Quebec H2L 4M1

0 studies enrolling now · 4 studies all time

What they study most

Epilepsy, Melanoma, Seizures, Solid Tumors

Studies at this site

• Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial — Completed
• Study of Atezolizumab in Combination With Cobimetinib in Participants With Locally Advanced or Metastatic Solid Tumors — Completed
• A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma — Completed
• Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy — Completed